A rapid growth in the incidence of orthopaedic injuries and musculoskeletal diseases are primary factors likely to drive the demands of orthobiologics products. Annually, more than 6.8 million patients receive medical care for orthopaedic injuries just in U.S. Demographical analyses predict that the aging population will double the number of patients with orthopaedic conditions within next 20 years. A similar trend is expected for patients with periodontal diseases, as older adults are more susceptible to dental conditions that require repairing of tissue defects.  These projections indicate increasing number of patients seeking bone and soft tissue grafting solutions at some point in their treatment cycle.

Existing bone grafting solutions face clinical limitations that results in infection, tissue reaction, prolong recovery, multiple surgical procedures, and inadequate bone formation. We are currently exploring the potential of Vitality3D to produce customised bone implants and grafts that mimic the structure and bioactivity of the microenvironment in native tissues, harnessing the power of natural biology for rapid and stable bone formation. This initiative aims to discover how the potential of our technology could transform dental and orthopaedic cares, aiming to improve patient outcomes and increase procedural efficiency as we progress.